| Autor: |
Zhang, Feng, Hu, Guan-hua, Zhang, Le-ping, Xu, Lan-ping, Suo, Pan, Wang, Yu, Bai, Lu, Liu, Kai-yan, Zhang, Xiao-hui, Huang, Xiao-jun, Cheng, Yi-fei |
| Předmět: |
|
| Zdroj: |
Leukemia & Lymphoma; Mar2024, Vol. 65 Issue 3, p383-388, 6p |
| Abstrakt: |
This letter to the editor discusses the outcomes of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with the "Beijing protocol" in pediatric myeloid neoplasms post cytotoxic therapy (MN-pCT). MN-pCT is a rare complication in pediatric cancer survivors, and research on this population is limited. The study reports the outcomes of pediatric patients with MN-pCT who underwent haplo-HSCT, which is the only treatment providing long-term survival. The study found that haplo-HSCT using the Beijing protocol resulted in long-term survival with low treatment-related mortality. The authors suggest that haplo-HSCT may be a suitable alternative when matched sibling or unrelated donors are unavailable. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
